<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="efemp2-cutis-laxa" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">efemp2-cutis-laxa</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">EFEMP2</italic>-Related Cutis Laxa</title>
        <alt-title alt-title-type="alt-title">Synonyms: Autosomal Recessive Cutis Laxa Type 1B, ARCL1B</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Loeys</surname>
            <given-names>Bart</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Center for Medical Genetics<break/>Antwerp University Hospital<break/>Antwerp, Belgium</aff>
          <email>bart.loeys@uantwerp.be</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Paepe</surname>
            <given-names>Anne</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Center for Medical Genetics<break/>Ghent University Hospital<break/>Ghent, Belgium</aff>
          <email>anne.depaepe@ugent.be</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Urban</surname>
            <given-names>Zsolt</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Department of Human Genetics<break/>Graduate School of Public Health<break/>University of Pittsburgh<break/>Pittsburgh, Pennsylvania</aff>
          <email>urbanz@pitt.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2011-05-12" date-type="created">
          <day>12</day>
          <month>5</month>
          <year>2011</year>
        </date>
        <date iso-8601-date="2015-07-23" date-type="updated">
          <day>23</day>
          <month>7</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="dbmd" document-type="chapter">Dystrophinopathies</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="cyclic-n" document-type="chapter">
<italic toggle="yes">ELANE</italic>-Related Neutropenia</related-object>
      <abstract id="efemp2-cutis-laxa.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">EFEMP2</italic>-related cutis laxa, or autosomal recessive cutis laxa type 1B (ARCL1B), is characterized by cutis laxa and systemic involvement, most commonly arterial tortuosity, aneurysms, and stenosis; retrognathia; joint laxity; and arachnodactyly. Severity ranges from perinatal lethality as a result of cardiopulmonary failure to manifestations limited to the vascular and craniofacial systems.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">EFEMP2</italic>-related cutis laxa is established by clinical diagnostic criteria. Pathogenic variants in <italic toggle="yes">EFEMP2</italic> (also known as <italic toggle="yes">FBLN4</italic>) are causative.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Routine repair of hernias; symptomatic treatment of pulmonary emphysema. Treatment of aortic root dilatation with beta-blockers and angiotensin-receptor inhibitors can be considered. Aortic aneurysm replacement has been performed successfully. Joint hypermobility can be supported by muscle-reinforcing physical therapy.</p>
          <p><italic toggle="yes">Surveillance:</italic> Regular cardiovascular and pulmonary follow up starting at birth or at the time of diagnosis. Annual MR angiography from head to pelvis.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Cigarette smoking to avoid worsening of emphysema, sun tanning to protect skin.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">EFEMP2</italic>-related cutis laxa is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3. Carrier testing and prenatal diagnosis of <italic toggle="yes">EFEMP2</italic>-related cutis laxa are possible once the pathogenic variants have been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="efemp2-cutis-laxa.Diagnosis">
        <title>Diagnosis</title>
        <sec id="efemp2-cutis-laxa.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>The diagnosis of <italic toggle="yes">EFEMP2</italic>-related cutis laxa <bold>should be suspected</bold> in individuals with the following clinical characteristics:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Cutis laxa.</bold> Furrowing of the skin of the whole body that can be displaced more than normal skin and shows abnormal recoil; the skin has a &#x0201c;doughy&#x0201d; consistency. It does not display redundancy as in the Ehlers-Danlos syndromes.</p>
            </list-item>
            <list-item>
              <p><bold>Arterial involvement.</bold> Arterial tortuosity with aortic and arterial aneurysms and stenosis (the isthmus aorta in particular is often stenotic); pulmonary hypertension, stenosis and dilatation of pulmonary arteries; hemorrhagic stroke</p>
            </list-item>
            <list-item>
              <p><bold>Respiratory involvement.</bold> Emphysema, diaphragmatic hernia or hypoplasia</p>
            </list-item>
            <list-item>
              <p><bold>Craniofacial involvement.</bold> Midface retrusion, retrognathia, widely spaced eyes, high palate</p>
            </list-item>
            <list-item>
              <p>
                <bold>Other evidence of a generalized connective disorder</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Joint laxity or contractures</p>
                </list-item>
                <list-item>
                  <p>Arachnodactyly</p>
                </list-item>
                <list-item>
                  <p>Pectus excavatum</p>
                </list-item>
                <list-item>
                  <p>Inguinal hernias</p>
                </list-item>
                <list-item>
                  <p>Hypotonia</p>
                </list-item>
                <list-item>
                  <p>Bone fragility</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="efemp2-cutis-laxa.Establishing_the_Diagn">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">EFEMP2</italic>-related cutis laxa <bold>is established</bold> in a proband with the identification of biallelic pathogenic variants in <italic toggle="yes">EFEMP2</italic> (also known as <italic toggle="yes">FBLN4</italic>). See <xref ref-type="table" rid="efemp2-cutis-laxa.T.summary_of_molecular">Table 1</xref>.</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold> and use of a <bold>multi-gene panel</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">EFEMP2</italic> is performed first and followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">EFEMP2</italic> and other genes of interest (see <xref ref-type="sec" rid="efemp2-cutis-laxa.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and sensitivity of multi-gene panels vary by laboratory and over time.</p>
            </list-item>
          </list>
          <table-wrap id="efemp2-cutis-laxa.T.summary_of_molecular" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">EFEMP2</italic>-Related Cutis Laxa</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_efemp2-cutis-laxa.T.summary_of_molecular_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_efemp2-cutis-laxa.T.summary_of_molecular_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_efemp2-cutis-laxa.T.summary_of_molecular_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_efemp2-cutis-laxa.T.summary_of_molecular_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">EFEMP2</italic>
                  </td>
                  <td headers="hd_h_efemp2-cutis-laxa.T.summary_of_molecular_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_efemp2-cutis-laxa.T.summary_of_molecular_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;95%</td>
                </tr>
                <tr>
                  <td headers="hd_h_efemp2-cutis-laxa.T.summary_of_molecular_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_efemp2-cutis-laxa.T.summary_of_molecular_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_efemp2-cutis-laxa.T.summary_of_molecular_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_efemp2-cutis-laxa.T.summary_of_molecular_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_efemp2-cutis-laxa.T.summary_of_molecular_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="efemp2-cutis-laxa.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="efemp2-cutis-laxa" object-id="efemp2-cutis-laxa.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="efemp2-cutis-laxa.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="efemp2-cutis-laxa.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="efemp2-cutis-laxa.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="efemp2-cutis-laxa.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="efemp2-cutis-laxa.TF.1.5">
                <label>5. </label>
                <p>Cutis laxa is genetically heterogeneous and currently known genes do not account for all patients [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.callewaert.2013.111">Callewaert et al 2013</xref>, <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.urban.2014.16">Urban &#x00026; Davis 2014</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="efemp2-cutis-laxa.Clinical_Characteristi">
        <title>Clinical Characteristics</title>
        <sec id="efemp2-cutis-laxa.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">EFEMP2</italic>-related cutis laxa (autosomal recessive cutis laxa type 1B, ARCL1B) is a highly variable disorder ranging from perinatal lethality caused by cardiopulmonary failure [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hoyer.2009.276">Hoyer et al 2009</xref>] to manifestations limited to the vascular and craniofacial systems [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.renard.2010.895">Renard et al 2010</xref>]. The most common shared features besides cutis laxa include arterial tortuosity, aneurysms, and stenosis; retrognathia; joint laxity; and arachnodactyly. Features present in the currently known affected individuals are summarized below [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hucthagowder.2006.1075">Hucthagowder et al 2006</xref>, <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.dasouki.2007.2635">Dasouki et al 2007</xref>, <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hoyer.2009.276">Hoyer et al 2009</xref>, <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.renard.2010.895">Renard et al 2010</xref>, <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.kappanayil.2012.61">Kappanayil et al 2012</xref>, <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.sawyer.2013.1148">Sawyer et al 2013</xref>, <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hebson.2014.671">Hebson et al 2014</xref>].</p>
          <p><bold>Cardiovascular.</bold> The most typical cardiovascular findings are marked aortic dilatation, aortic and arterial tortuosity, isthmic aortic narrowing, and dilatation/stenosis of the pulmonary arteries. Aberrant branching of the right pulmonary artery was also a frequent finding. Additional cardiovascular findings that have been described occasionally include cardiac hypertrophy, bradycardia [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.dasouki.2007.2635">Dasouki et al 2007</xref>, <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hoyer.2009.276">Hoyer et al 2009</xref>], pulmonary hypertension, and tricuspid insufficiency [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.dasouki.2007.2635">Dasouki et al 2007</xref>]. In a cohort of 16 affected individuals from India almost all died from cardiopulmonary failure in the neonatal period [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.nampoothiri.2010">Nampoothiri et al 2010</xref>]. Other patients underwent successful aortic surgery and survived [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.sawyer.2013.1148">Sawyer et al 2013</xref>, <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hebson.2014.671">Hebson et al 2014</xref>].</p>
          <p><bold>Skin.</bold> Although <italic toggle="yes">EFEMP2</italic>-related cutis laxa is classified within the cutis laxa group, skin findings can be minor or even normal. If present, pertinent skin findings include cutis laxa and thin translucent or velvety skin.</p>
          <p><bold>Craniofacial.</bold> Most recurrent characteristics are retrognathia, widely spaced eyes, high palate, and dysplastic ears. Additional features include long philtrum with thin vermilion of the upper lip and prominent eyes.</p>
          <p><bold>Lung.</bold> Developmental emphysema has been described in one patient [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hoyer.2009.276">Hoyer et al 2009</xref>] but emphysema is more typical for <related-object link-type="booklink" source-id="gene" document-id="fbln5-cutis-laxa" document-type="chapter"><italic toggle="yes">FBLN5</italic>-associated cutis laxa</related-object> (type 1B). In the reported patient, lung problems may also be related to diaphragmatic hypoplasia.</p>
          <p><bold>Musculoskeletal.</bold> Individuals with <italic toggle="yes">EFEMP2</italic>-related cutis laxa usually present with muscle hypotonia. Other common findings are arachnodactyly, joint laxity, and pectus deformities. Fractures also appear to be common [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hoyer.2009.276">Hoyer et al 2009</xref>]. Additional skeletal observations were soft cranial bones, bowing and elongation of the long bones, and flaring of the metaphyses.</p>
          <p><bold>Other.</bold> Inguinal hernias may be present.</p>
        </sec>
        <sec id="efemp2-cutis-laxa.GenotypePhenotype_Corr">
          <title>Genotype-Phenotype Correlations</title>
          <p>No clinically significant genotype-phenotype correlations have emerged.</p>
        </sec>
        <sec id="efemp2-cutis-laxa.Prevalence">
          <title>Prevalence</title>
          <p>Very few reliable estimates of prevalence of cutis laxa exist. A prevalence at birth for all types of cutis laxa is 1:4,000,000 according to the Rhone-Alps Eurocat Registry [E Robert, personal observation].</p>
        </sec>
      </sec>
      <sec id="efemp2-cutis-laxa.Genetically_Related_Al">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">EFEMP2</italic> (<italic toggle="yes">FBLN4</italic>).</p>
        <p>Individuals without cutis laxa ascertained based on the presence of arterial tortuosity, stenosis, and aneurysms can have pathogenic variants in <italic toggle="yes">EFEMP2</italic> [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.renard.2010.895">Renard et al 2010</xref>]. This phenotype is considered to be a variant of the <italic toggle="yes">EFEMP2</italic>-related cutis laxa phenotypic spectrum with variable expression or reduced penetrance of cutis laxa rather than a distinct disorder. (See <xref ref-type="sec" rid="efemp2-cutis-laxa.Clinical_Description">Clinical Description</xref>.)</p>
      </sec>
      <sec id="efemp2-cutis-laxa.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other disorders characterized by cutis laxa are summarized in <xref ref-type="table" rid="efemp2-cutis-laxa.T.disorders_to_conside">Table 2</xref>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="fbln5-cutis-laxa" document-type="chapter"><bold><italic toggle="yes">FBLN5-</italic>related cutis laxa</bold></related-object>
<bold>(ARCL1A and ADCL2)</bold> is characterized by cutis laxa, early childhood-onset pulmonary emphysema, peripheral pulmonary artery stenosis, and other evidence of a generalized connective disorder such as inguinal hernias and hollow viscus diverticula (e.g., intestine, bladder). Occasionally, supravalvular aortic stenosis is observed. Intrafamilial variability in age of onset is observed. Cardiorespiratory failure from complications of pulmonary emphysema (respiratory or cardiac insufficiency) is the most common cause of death. <italic toggle="yes">FBLN5</italic>-related cutis laxa can be inherited in an autosomal recessive or autosomal dominant manner. Autosomal recessive inheritance is more common.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="ltbp4-cutis-laxa" document-type="chapter"><bold><italic toggle="yes">LTBP4</italic>-related cutis laxa</bold></related-object>
<bold>(ARCL1C, cutis laxa with severe pulmonary, gastrointestinal and urinary abnormalities, Urban-Rifkin-Davis syndrome [URDS])</bold> is characterized by abnormal pulmonary, gastrointestinal, urinary, musculoskeletal, craniofacial, and dermal development. All affected individuals had severe respiratory distress with cystic and atelectatic changes in the lungs complicated by tracheomalacia and diaphragmatic hernia. Cardiovascular lesions were mild and limited to pulmonary artery stenosis and patent foramen ovale. Gastrointestinal malformations included diverticulosis and enlargement, tortuosity, and stenosis at various levels of the intestinal tract. The urinary tract was affected by diverticulosis and hydronephrosis. Joint laxity and low muscle tone contributed to musculoskeletal problems compounded by postnatal growth delay. Craniofacial features included microretrognathia, flat midface, receding forehead, and wide anterior fontanels. The craniofacial and pulmonary phenotype of URDS is similar to <italic toggle="yes">EFEMP2</italic>-related cutis laxa. Differences include relatively mild cardiovascular involvement in URDS and the presence of severe gastrointestinal and urinary complications, which have not been described to date in <italic toggle="yes">EFEMP2</italic>-related cutis laxa.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cutis-laxa" document-type="chapter"><bold><italic toggle="yes">ATP6V0A2</italic>-related cutis laxa</bold></related-object>
<bold>(ARCL2A)</bold> spans a phenotypic spectrum that includes Debr&#x000e9;-type cutis laxa at the severe end and wrinkly skin syndrome at the mild end. Affected individuals have furrowing of the skin of the whole body that improves with time. They may have other evidence of a generalized connective disorder, including enlarged anterior fontanel in infancy, congenital dislocation of the hips, inguinal hernias, and high myopia. In most (but not all) affected individuals, cortical and cerebellar malformations are present and are associated with severe developmental delays, seizures, and neurologic regression. Clinical features of ARCL2A not observed in <italic toggle="yes">EFEMP2</italic>-related cutis laxa are: intellectual disability, hip dislocation, and delayed closure of the fontanel. Secondary effects of strokes (developmental delay, structural brain defects) [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hoyer.2009.276">Hoyer et al 2009</xref>, <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.renard.2010.895">Renard et al 2010</xref>] may complicate the distinction between ARCL2A and ARCL1B. In ARCL2A, abnormal serum transferrin (N-glycosylation test) and apolipoprotein CIII (O-glycosylation test) isoelectric focusing (IEF) may help confirm the diagnosis. <italic toggle="yes">ATP6V0A2</italic>-related cutis laxa is inherited in an autosomal recessive manner.</p>
        <p><bold><italic toggle="yes">ELN</italic>-related cutis laxa (ADCL1)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/123700">OMIM</ext-link>) was historically considered a strictly cutaneous disorder without systemic involvement; however, it is now known that persons with <italic toggle="yes">ELN</italic> pathogenic variants can also have aortic aneurysms that require aortic root replacement or lead to aortic rupture in early adulthood. The aortic pathology of these aneurysms is indistinguishable from that of <related-object link-type="booklink" source-id="gene" document-id="marfan" document-type="chapter">Marfan syndrome</related-object>. It remains to be seen whether <italic toggle="yes">ELN</italic> is mutated in persons with thoracic aortic aneurysms and aortic dissections (TAAD) [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.szabo.2006.255">Szabo et al 2006</xref>] (see <related-object link-type="booklink" source-id="gene" document-id="taa" document-type="chapter">Thoracic Aortic Aneurysms and Aortic Dissections</related-object>). Adult-onset emphysema has also been reported in ADCL [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.urban.2005.1193">Urban et al 2005</xref>]. The following manifestations distinguish <italic toggle="yes">EFEMP2</italic> -related cutis laxa from ADCL1: arterial tortuosity, infantile aneurysms, infantile developmental emphysema, death in infancy or early childhood, arachnodactyly, and retrognathia. <italic toggle="yes">ELN</italic>-related cutis laxa is inherited in an autosomal dominant manner.</p>
        <p><bold>Gerodermia osteodysplastica (GO)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/231070">OMIM</ext-link>). Onset occurs in infancy or early childhood (for review, see <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.nanda.2008.66">Nanda et al [2008]</xref>). Children appear older than their age as a result of sagging cheeks and jaw hypoplasia. Skin wrinkling is less severe than in persons with cutis laxa and is confined to the dorsum of the hands and feet and to the abdomen when in the sitting position. A generalized connective tissue weakness leads to frequent hip dislocation and hernias; however, GO can be distinguished from other types of cutis laxa by the presence of osteopenia/osteoporosis and fractures, most commonly vertebral compression fractures, but also fractures of the long bones. However, fractures have also been described in <italic toggle="yes">EFEMP2</italic> -related cutis laxa [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hucthagowder.2006.1075">Hucthagowder et al 2006</xref>, <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hoyer.2009.276">Hoyer et al 2009</xref>]. Intellectual development is in the normal range. In contrast to ARCL2A, fontanel size and closure are normal; positioning of the palpebral fissures is normal; and disease manifestations do not become milder with age. Unlike <italic toggle="yes">EFEMP2</italic>-related cutis laxa, GO is generally not associated with cardiovascular and pulmonary manifestations. Pathogenic variants in <italic toggle="yes">GORAB</italic> are causative [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hennies.2008.1410">Hennies et al 2008</xref>]. GO is inherited in an autosomal recessive manner.</p>
        <p><bold>De Barsy syndrome</bold>
<bold>(ARCL3A and ARCL3B)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/219150">OMIM</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/614438">OMIM</ext-link>) is characterized by a progeroid appearance, pre- and postnatal growth retardation, moderate to severe intellectual disability, corneal clouding or cataracts, and generalized cutis laxa [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.guerra.2004.616">Guerra et al 2004</xref>]. The progeroid appearance is not caused by skin sagging, but rather by a hypoplasia of the dermis. Joint hyperlaxity, pseudo-athetoid movements, and hyperreflexia are observed. Inheritance is autosomal recessive; the gene in which mutation is causative is not known. Like GO, de Barsy syndrome is not associated with cardiovascular and pulmonary involvement. De Barsy syndrome is inherited in an autosomal recessive manner.</p>
        <table-wrap id="efemp2-cutis-laxa.T.disorders_to_conside" position="anchor" orientation="portrait">
          <label>Table 2. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of Cutis Laxa</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_1">Disease Name</th>
                <th id="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_2">Gene</th>
                <th id="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_3">OMIM</th>
                <th id="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_4" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_4">MOI</th>
                <th id="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5" valign="middle" colspan="5" align="left" scope="colgroup" rowspan="1">Clinical Findings</th>
              </tr>
              <tr>
                <th headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5" id="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">CL</th>
                <th headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5" id="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Emphysema</th>
                <th headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5" id="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Aneurysm</th>
                <th headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5" id="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">ID</th>
                <th headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5" id="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">GI &#x00026; GU<break/>Malformation</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ARCL1A</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">FBLN5</italic>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/219100">219100</ext-link>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ARCL1B</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">EFEMP2</italic>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/614437">614437</ext-link>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ARCL1C (URDS)</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">LTBP4</italic>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/613177">613177</ext-link>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ARCL2A</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ATP6V0A2</italic>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/219200">219200</ext-link>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ARCL2B</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PYCR1</italic>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/612940">612940</ext-link>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ADCL1</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ELN</italic>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/123700">123700</ext-link>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ADCL2</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">FBLN5</italic>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/614434">614434</ext-link>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">GO</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.genenames.org/cgi-bin/gene_symbol_report?match=GORAB">GORAB</ext-link>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/231070">231070</ext-link>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+ +</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">De Barsy syndrome<break/>(ARCL3)</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ALDH18A1</italic>, <italic toggle="yes">PYCR1</italic></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/219150">219150</ext-link>,<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/614438">614438</ext-link></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
                <td headers="hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_1_5 hd_h_efemp2-cutis-laxa.T.disorders_to_conside_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>CL = cutis laxa</p>
            </fn>
            <fn>
              <p>ID = intellectural disability</p>
            </fn>
            <fn>
              <p>URDS = Urban-Rifkin-Davis syndrome</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="efemp2-cutis-laxa.Management">
        <title>Management</title>
        <sec id="efemp2-cutis-laxa.Evaluations_Following">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">EFEMP2</italic> -related cutis laxa, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Chest roentgenogram</p>
            </list-item>
            <list-item>
              <p>Echocardiography</p>
            </list-item>
            <list-item>
              <p>3D-CT scan</p>
            </list-item>
            <list-item>
              <p>Lung function test</p>
            </list-item>
            <list-item>
              <p>MR angiography (MRA) from head to pelvis</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="efemp2-cutis-laxa.Treatment_of_Manifesta">
          <title>Treatment of Manifestations</title>
          <list list-type="bullet">
            <list-item>
              <p><bold>Hernia.</bold> Routine repair is appropriate.</p>
            </list-item>
            <list-item>
              <p><bold>Pulmonary emphysema</bold> is treated symptomatically. Tracheostomy may be necessary when retrognathia leads to upper airway obstruction.</p>
            </list-item>
            <list-item>
              <p><bold>Arterial abnormalities.</bold> No definitive treatment is available. Based on experience in other related disorders (e.g., <related-object link-type="booklink" source-id="gene" document-id="marfan" document-type="chapter">Marfan syndrome</related-object>), treatment with beta-blockers or angiotensin receptor blockers can be considered when aortic root dilatation is present. However, the efficacy of these interventions in <italic toggle="yes">EFEMP2</italic>- related disorders has not been proven. Surgical repair of large aortic aneurysms (at risk for dissection) should be considered. Aortic aneurysm replacement has been performed successfully</p>
            </list-item>
            <list-item>
              <p><bold>Joint hypermobility</bold> can be supported by muscle reinforcing physical therapy.</p>
            </list-item>
          </list>
        </sec>
        <sec id="efemp2-cutis-laxa.Surveillance">
          <title>Surveillance</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Regular cardiovascular and pulmonary follow up starting at birth or at the time of diagnosis</p>
            </list-item>
            <list-item>
              <p>Annual MRA from head to pelvis</p>
            </list-item>
          </list>
        </sec>
        <sec id="efemp2-cutis-laxa.AgentsCircumstances_to">
          <title>Agents/Circumstances to Avoid</title>
          <p>Avoid the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Cigarette smoking, which can worsen emphysema</p>
            </list-item>
            <list-item>
              <p>Sun tanning, which can damage skin</p>
            </list-item>
          </list>
        </sec>
        <sec id="efemp2-cutis-laxa.Evaluation_of_Relative">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger sibs of an affected individual by molecular genetic testing of the <italic toggle="yes">EFEMP2</italic> pathogenic variants in the family in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p>
          <p>See <xref ref-type="sec" rid="efemp2-cutis-laxa.Related_Genetic_Counse">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="efemp2-cutis-laxa.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>No experience with pregnancy in an affected proband has been reported.</p>
        </sec>
        <sec id="efemp2-cutis-laxa.Therapies_Under_Invest">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials related to this disorder.</p>
        </sec>
      </sec>
      <sec id="efemp2-cutis-laxa.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="efemp2-cutis-laxa.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">EFEMP2</italic>-related cutis laxa is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="efemp2-cutis-laxa.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">EFEMP2</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier of an <italic toggle="yes">EFEMP2</italic> pathogenic variant is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with <italic toggle="yes">EFEMP2</italic>-related cutis laxa are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">EFEMP2</italic>.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of an <italic toggle="yes">EFEMP2</italic> pathogenic variant.</p>
        </sec>
        <sec id="efemp2-cutis-laxa.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">EFEMP2</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="efemp2-cutis-laxa.Related_Genetic_Counse">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="efemp2-cutis-laxa.Evaluation_of_Relative">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="efemp2-cutis-laxa.Prenatal_Testing_and_P">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">EFEMP2</italic> pathogenic variants have been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for <italic toggle="yes">EFEMP2</italic>-related cutis laxa are possible options.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="efemp2-cutis-laxa.Resources">
        <title>Resources</title>
      </sec>
      <sec id="efemp2-cutis-laxa.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">EFEMP2</italic> has 11 exons and produces a 2002-bp long transcript, which in turn encodes a protein of 443 amino acid residues. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="efemp2-cutis-laxa" object-id="efemp2-cutis-laxa.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign allelic variants.</bold> See <xref ref-type="table" rid="efemp2-cutis-laxa.T.selected_efemp2_alle">Table 3</xref>.</p>
        <p><bold>Pathogenic allelic variants.</bold> See <xref ref-type="table" rid="efemp2-cutis-laxa.T.selected_efemp2_alle">Table 3</xref>.</p>
        <table-wrap id="efemp2-cutis-laxa.T.selected_efemp2_alle" position="anchor" orientation="portrait">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">EFEMP2</italic> Allelic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                <th id="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                  <bold>Benign</bold>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.775G&#x0003e;A&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Val259Ile&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_4" rowspan="11" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_016938">NM_016938.4</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_058634">NP_058634.4</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1126G&#x0003e;A&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg409Gln&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_1" rowspan="9" valign="middle" align="left" scope="row" colspan="1">
                  <bold>Pathogenic</bold>
                </td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.169G&#x0003e;A&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu57Lys&#x000a0;<sup>3</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.608A&#x0003e;C&#x000a0;<sup>4</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asp203Ala</td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.835C&#x0003e;T&#x000a0;<sup>5</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg279Cys&#x000a0;<sup>5</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1070_1073dupCCGC&#x000a0;<sup>5</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asp359fsTer360&#x000a0;<sup>5</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.800G&#x0003e;A&#x000a0;<sup>6</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Cys267Tyr&#x000a0;<sup>6</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.376G&#x0003e;A&#x000a0;<sup>7</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu126Lys&#x000a0;<sup>7</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1189G&#x0003e;A&#x000a0;<sup>7</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ala397Thr&#x000a0;<sup>7</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.377A&#x0003e;T&#x000a0;<sup>7</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu126Val&#x000a0;<sup>7</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.577delC&#x000a0;<sup>7</sup></td>
                <td headers="hd_h_efemp2-cutis-laxa.T.selected_efemp2_alle_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gln193fsTer204&#x000a0;<sup>7</sup></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="efemp2-cutis-laxa.TF.3.1">
              <label>1. </label>
              <p>
                <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=601314">rs601314</ext-link>
              </p>
            </fn>
            <fn id="efemp2-cutis-laxa.TF.3.2">
              <label>2. </label>
              <p>
                <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=61893867">rs61893867</ext-link>
              </p>
            </fn>
            <fn id="efemp2-cutis-laxa.TF.3.3">
              <label>3. </label>
              <p>
                <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hucthagowder.2006.1075">Hucthagowder et al [2006]</xref>
              </p>
            </fn>
            <fn id="efemp2-cutis-laxa.TF.3.4">
              <label>4. </label>
              <p>
                <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.nampoothiri.2010">Nampoothiri et al [2010]</xref>
              </p>
            </fn>
            <fn id="efemp2-cutis-laxa.TF.3.5">
              <label>5. </label>
              <p>
                <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.dasouki.2007.2635">Dasouki et al [2007]</xref>
              </p>
            </fn>
            <fn id="efemp2-cutis-laxa.TF.3.6">
              <label>6. </label>
              <p>
                <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hoyer.2009.276">Hoyer et al [2009]</xref>
              </p>
            </fn>
            <fn id="efemp2-cutis-laxa.TF.3.7">
              <label>7. </label>
              <p>
                <xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.renard.2010.895">Renard et al [2010]</xref>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> Fibulin-4 is a member of the fibulin family of extracellular matrix proteins. Fibulin-4 is known to associate with tropoelastin, possibly connecting elastin to microfibrils to form elastic fibers [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.kobayashi.2007.11805">Kobayashi et al 2007</xref>]. Fibulin-4 also binds strongly to the N-terminal region of fibrillin-1 in the presence of Ca<sup>2+</sup> [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.ono.2009.16872">Ono et al 2009</xref>]. Fibulin-4 can bind lysyl oxidase, an enzyme responsible for the crosslinking of elastin and collagen required for the integrity of the extracellular matrix [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.horiguchi.2009.19029">Horiguchi et al 2009</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">EFEMP2</italic> (<italic toggle="yes">FBLN4</italic>) impair the stability and/or secretion of fibulin-4 [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hucthagowder.2006.1075">Hucthagowder et al 2006</xref>], similarly to previous findings for fibulin-5 pathogenic variants [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hu.2006.3379">Hu et al 2006</xref>]. The resulting decrease of protein in the extracellular matrix may lead to altered interactions with fibulin-4 binding partners and, subsequently, to impaired elastogenesis. Fibulin-4 also competes with latent transforming growth factor-&#x003b2; (TGF&#x003b2;)-binding proteins (LTBPs) for binding to fibrillin-1 [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.ono.2009.16872">Ono et al 2009</xref>]. As such, this fibulin protein may modulate the sequestration of latent TGF&#x003b2; in the extracellular matrix. Consistent with this notion, increased TGF&#x003b2; signaling was found in tissues from persons with <italic toggle="yes">EFEMP2</italic> pathogenic variants [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.renard.2010.895">Renard et al 2010</xref>] and in a murine model of fibulin-4 deficiency [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.hanada.2007.738">Hanada et al 2007</xref>]. In addition, the resulting decrease of mutated fibulin-4 protein in the extracellular matrix may lead to defective terminal differentiation of vascular smooth muscle [<xref ref-type="bibr" rid="efemp2-cutis-laxa.REF.huang.2010.583">Huang et al 2010</xref>].</p>
      </sec>
      <sec id="efemp2-cutis-laxa.References">
        <title>References</title>
        <sec id="efemp2-cutis-laxa.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="efemp2-cutis-laxa.Literature_Cited.reflist0">
            <ref id="efemp2-cutis-laxa.REF.callewaert.2013.111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Callewaert</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Damme</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vlummens</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malfait</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanakker</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mac Neal</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salhi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heimdal</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Almeida</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaspar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prescott</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gosendi</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansour</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pi&#x000e9;rard</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madan-Khetarpal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sciurba</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Symoens</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coucke</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa.</article-title>
                <source>Hum Mutat.</source>
                <volume>34</volume>
                <fpage>111</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">22829427</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.dasouki.2007.2635">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dasouki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markova</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garola</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charbonneau</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakai</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Compound heterozygous mutations in fibulin-4 causing neonatal lethal pulmonary artery occlusion, aortic aneurysm, arachnodactyly, and mild cutis laxa.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>143A</volume>
                <fpage>2635</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">17937443</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.guerra.2004.616">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerra</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fornieri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacchelli</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lugli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torelli</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The De Barsy syndrome.</article-title>
                <source>J Cutan Pathol.</source>
                <volume>31</volume>
                <fpage>616</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">15330994</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.hanada.2007.738">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeij</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garinis</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Waard</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunen</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duncker</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijers</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietz</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanaar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Essers</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice.</article-title>
                <source>Circ Res.</source>
                <volume>100</volume>
                <fpage>738</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">17293478</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.hebson.2014.671">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hebson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clabby</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sallee</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shankar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loeys</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Laer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kogon</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Severe aortopathy due to fibulin-4 deficiency: molecular insights, surgical strategy, and a review of the literature.</article-title>
                <source>Eur J Pediatr.</source>
                <volume>173</volume>
                <fpage>671</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">24276535</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.hennies.2008.1410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hennies</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egerer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seifert</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000fc;hnisch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Budde</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000e4;tebus</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brancati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajab</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zampino</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fodale</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dallapiccola</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metcalfe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton-Smith</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tassabehji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barr</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieacker</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Gerodermia osteodysplastica is caused by mutations in SCYL1BP1, a Rab-6 interacting golgin.</article-title>
                <source>Nat Genet.</source>
                <volume>40</volume>
                <fpage>1410</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">18997784</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.horiguchi.2009.19029">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horiguchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohbayashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marmorstein</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yabe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takagi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akama</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>106</volume>
                <fpage>19029</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">19855011</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.hoyer.2009.276">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoyer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammersen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geppert</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Lethal cutis laxa with contractural arachnodactyly, overgrowth and soft tissue bleeding due to a novel homozygous fibulin-4 gene mutation.</article-title>
                <source>Clin Genet</source>
                <volume>76</volume>
                <fpage>276</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">19664000</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.hu.2006.3379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loeys</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coucke</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecham</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Fibulin-5 mutations: mechanisms of impaired elastic fiber formation in recessive cutis laxa.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>15</volume>
                <fpage>3379</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">17035250</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.huang.2010.583">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Budatha</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marmorstein</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Word</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanagisawa</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression.</article-title>
                <source>Circ Res.</source>
                <volume>106</volume>
                <fpage>583</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">20019329</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.hucthagowder.2006.1075">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hucthagowder</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sausgruber</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angle</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marmorstein</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <volume>78</volume>
                <fpage>1075</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">16685658</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.kappanayil.2012.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kappanayil</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nampoothiri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kannan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coucke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malfait</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravindran</surname>
                    <given-names>HK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurup</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faiyaz-Ul-Haque</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Characterization of a distinct lethal arteriopathy syndrome in twenty-two infants associated with an identical, novel mutation in FBLN4 gene, confirms fibulin-4 as a critical determinant of human vascular elastogenesis.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2012</year>
                <volume>7</volume>
                <fpage>61</fpage>
                <pub-id pub-id-type="pmid">22943132</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.kobayashi.2007.11805">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kostka</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbe</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keene</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e4;chinger</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanisch</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markova</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timpl</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization.</article-title>
                <source>J Biol Chem.</source>
                <volume>282</volume>
                <fpage>11805</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">17324935</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.nampoothiri.2010">
              <mixed-citation publication-type="confproc">Nampoothiri S, Kappanayil M, De Paepe A, Loeys B, Van Laer L, Kannan R, Faiyaz-Ul-Haque M, Krishna Kumar R. Lethal vascular syndrome from South India due to a novel mutation in fibulin 4. Abstract c16.3. Gothenburg, Sweden: European Society of Human Genetics Conference. 2010.</mixed-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.nanda.2008.66">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nanda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alsaleh</surname>
                    <given-names>QA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Sabah</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marzouk</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salam</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nanda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anim</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <article-title>Gerodermia osteodysplastica/wrinkly skin syndrome: report of three patients and brief review of the literature.</article-title>
                <source>Pediatr Dermatol.</source>
                <year>2008</year>
                <volume>25</volume>
                <fpage>66</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">18304158</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.ono.2009.16872">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sengle</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charbonneau</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlberg</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e4;chinger</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee-Arteaga</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zilberberg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rifkin</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramirez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakai</surname>
                    <given-names>LY</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites.</article-title>
                <source>J Biol Chem.</source>
                <volume>284</volume>
                <fpage>16872</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">19349279</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.renard.2010.895">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holm</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veith</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callewaert</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ad&#x000e8;s</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baspinar</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pickart</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dasouki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trapane</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Earing</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coucke</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakai</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietz</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loeys</surname>
                    <given-names>BL</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Altered TGFbeta signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency.</article-title>
                <source>Eur J Hum Genet.</source>
                <volume>18</volume>
                <fpage>895</fpage>
                <lpage>901</lpage>
                <pub-id pub-id-type="pmid">20389311</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.sawyer.2013.1148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sawyer</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dicke</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajapkse</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rebeyka</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McInnes</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parboosingh</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernier</surname>
                    <given-names>FP</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Longer term survival of a child with autosomal recessive cutis laxa due to a mutation in FBLN4.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>161A</volume>
                <fpage>1148</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">23532871</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.szabo.2006.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Szabo</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crepeau</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephan</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puntel</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yin Loke</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirk</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Aortic aneurysmal disease and cutis laxa caused by defects in the elastin gene.</article-title>
                <source>J Med Genet.</source>
                <volume>43</volume>
                <fpage>255</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16085695</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.urban.2014.16">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <article-title>Cutis laxa: intersection of elastic fiber biogenesis, TGF&#x003b2; signaling, the secretory pathway and metabolism.</article-title>
                <source>Matrix Biol.</source>
                <year>2014</year>
                <volume>33</volume>
                <fpage>16</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">23954411</pub-id>
              </element-citation>
            </ref>
            <ref id="efemp2-cutis-laxa.REF.urban.2005.1193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pope</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Autosomal dominant cutis laxa with severe lung disease: synthesis and matrix deposition of mutant tropoelastin.</article-title>
                <source>J Invest Dermatol</source>
                <volume>124</volume>
                <fpage>1193</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15955094</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="efemp2-cutis-laxa.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="efemp2-cutis-laxa.Author_Notes">
          <title>Author Notes</title>
          <p>Bart Loeys, MD, PhD<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.genetica-antwerpen.be/">Center for Medical Genetics, Antwerp University Hospital</ext-link></p>
          <p>Anne De Paepe, MD, PhD<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cmgg.be/en">Center for Medical Genetics, Ghent University Hospital</ext-link></p>
          <p>Zsolt Urban, PhD<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.publichealth.pitt.edu/human-genetics?id=99">Graduate School of Public Health, Department of Human Genetics, University of Pittsburgh</ext-link></p>
        </sec>
        <sec id="efemp2-cutis-laxa.Acknowledgments">
          <title>Acknowledgments</title>
          <p>This work was funded in part by a March of Dimes grant (1-FY09-556 to ZU) and an NIH/NHLBI grant (HL090648 to ZU), a &#x02018;Methusalem grant&#x02019; from the Flemish government and Ghent University (08/01M01108 to ADP), and an EC-FP7 project (FAD). BL is a senior clinical investigator of the fund for scientific research Flanders.</p>
        </sec>
        <sec id="efemp2-cutis-laxa.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>23 July 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>12 May 2011 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>9 July 2010 (bl) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
